Clinical studies have shown that the plasma levels of IL-1β are higher in CAD patients in comparison to non-CAD patients, and this finding is associated with an increased incidence of cardiovascular events in patients who have atherosclerotic risk factors [41–43]. The gene discussed is IL1B; the disease is coronary artery disorder.